Class-action lawsuits make news for their big sums – last year, pharmaceutical giant Merck settled a suit over its heart drug Vioxx for $37-million – but a more prosaic challenge gets less attention.
Donations from two private sources, matched by funding from the Canada Brain Research Fund, will deliver $46 million to neuroscience research over the course of the next five years.
With our tips articles, we aim to provide you with information that can help you improve patient care, better manage your office and tend to your financial needs. Here are six of the best stories from the past year.
VANCOUVER | An innovative pilot of a non-pharmaceutical, pre-surgical infection prevention treatment has proven itself highly successful at reducing the numbers of surgical site infections that occur yearly at Vancouver General Hospital.
